Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2004 3
2005 3
2006 2
2008 2
2009 1
2010 3
2011 4
2012 4
2013 1
2014 1
2015 2
2016 3
2017 3
2018 4
2019 3
2020 5
2021 8
2022 8
2023 1
2024 1
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

58 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of three antiretroviral therapy regimens for treatment-naive African adults living with HIV-2 (FIT-2): a pilot, phase 2, non-comparative, open-label, randomised controlled trial.
Eholie SP, Ekouevi DK, Chazallon C, Charpentier C, Messou E, Diallo Z, Zoungrana J, Minga A, Ngom Gueye NF, Hawerlander D, Dembele F, Colin G, Tchounga B, Karcher S, Le Carrou J, Tchabert-Guié A, Toni TD, Ouédraogo AS, Bado G, Toure Kane C, Seydi M, Poda A, Mensah E, Diallo I, Drabo YJ, Anglaret X, Brun-Vezinet F; FIT-2 study group. Eholie SP, et al. Lancet HIV. 2024 Jun;11(6):e380-e388. doi: 10.1016/S2352-3018(24)00085-7. Epub 2024 May 10. Lancet HIV. 2024. PMID: 38740027 Free article. Clinical Trial.
Mutations in the 3'-PPT Lead to HIV-1 Replication without Integration.
Richetta C, Subra F, Malet I, Leh H, Charpentier C, Corona A, Collin G, Descamps D, Deprez E, Parissi V, Calvez V, Tramontano E, Marcelin AG, Delelis O. Richetta C, et al. Among authors: collin g. J Virol. 2022 Jul 27;96(14):e0067622. doi: 10.1128/jvi.00676-22. Epub 2022 Jun 27. J Virol. 2022. PMID: 35758669 Free PMC article.
HIV-2 Vif Diversity Among Defective and Nondefective Sequences.
Bertine M, Visseaux B, Storto A, Collin G, Matheron S, Descamps D, Charpentier C; ANRS CO5 HIV-2 Cohort. Bertine M, et al. Among authors: collin g. J Acquir Immune Defic Syndr. 2016 May 1;72(1):e9-e11. doi: 10.1097/QAI.0000000000000924. J Acquir Immune Defic Syndr. 2016. PMID: 26689972 No abstract available.
Ibalizumab shows in-vitro activity against group A and group B HIV-2 clinical isolates.
Le Hingrat Q, Collin G, Bachelard A, Ghosn J, Chalal S, Pacanowski J, Peytavin G, Weinheimer S, Marsolais C, Damond F, Matheron S, Charpentier C, Descamps D; ANRS CO5 HIV-2 cohort. Le Hingrat Q, et al. Among authors: collin g. AIDS. 2022 Jul 1;36(8):1055-1060. doi: 10.1097/QAD.0000000000003218. Epub 2022 Mar 7. AIDS. 2022. PMID: 35262531
Minority resistant variants are also present in HIV-2-infected antiretroviral-naive patients.
Storto A, Visseaux B, Bertine M, Le Hingrat Q, Collin G, Damond F, Khuong MA, Blum L, Tubiana R, Karmochkine M, Cazanave C, Matheron S, Descamps D, Charpentier C; ANRS HIV-2 CO5 Cohort. Storto A, et al. Among authors: collin g. J Antimicrob Chemother. 2018 May 1;73(5):1173-1176. doi: 10.1093/jac/dkx530. J Antimicrob Chemother. 2018. PMID: 29415189
HPV 16 in squamous cell carcinoma of 19th century tonsils.
Benmoussa N, Charpentier C, Mariaggi AA, Collin G, Descamps D, Hourseau M, Barry B, Albert S, Picard A, Conan P, Charlier P. Benmoussa N, et al. Among authors: collin g. Lancet Oncol. 2016 Nov;17(11):e477-e478. doi: 10.1016/S1470-2045(16)30432-6. Lancet Oncol. 2016. PMID: 27819244 No abstract available.
Zika virus in the female genital tract.
Visseaux B, Mortier E, Houhou-Fidouh N, Brichler S, Collin G, Larrouy L, Charpentier C, Descamps D. Visseaux B, et al. Among authors: collin g. Lancet Infect Dis. 2016 Nov;16(11):1220. doi: 10.1016/S1473-3099(16)30387-5. Lancet Infect Dis. 2016. PMID: 27788975 No abstract available.
Earlier In Vitro Viral Production With SARS-CoV-2 Alpha Than With Beta, Gamma, B, or A.27 Variants.
Lebourgeois S, Chenane HR, Houhou-Fidouh N, Menidjel R, Ferré VM, Collin G, Benmalek N, Coppée R, Larrouy L, Yazdanpanah Y, Timsit JF, Charpentier C, Descamps D, Visseaux B. Lebourgeois S, et al. Among authors: collin g. Front Cell Infect Microbiol. 2021 Dec 16;11:792202. doi: 10.3389/fcimb.2021.792202. eCollection 2021. Front Cell Infect Microbiol. 2021. PMID: 34976868 Free PMC article.
58 results